Sign up for a free trial and join thousands of other leading professionals. Click here to start!

Acute Myeloid Leukemia News

Home | Index > Health > Cancer > Acute Myeloid Leukemia

TAKE THIS POLL
Is Belgian Prime Minister Herman Van Rompuy the right person to lead the EU as its president? (Nov. 20, 2009) Yes. No. Don't know.

Sort by: relevance (24 hours) relevance date

Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data 24 Nov 2009 16:54 GMT
... Tyrosine Kinase (RTK) Inhibitor, in a First-in-Human (FIH) Phase 1 AML Study Session Name: Acute Myeloid Leukemia - Therapy, excluding Transplantation II Date: Monday, December 7, 2009, 5:45pm (session: 4:30 - ...
Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting (PRN) 24 Nov 2009 16:53 GMT
... Tyrosine Kinase (RTK) Inhibitor, in a First-in-Human (FIH) Phase 1 AML Study Session Name: Acute Myeloid Leukemia - Therapy, excluding Transplantation II Date: Monday, December 7, 2009, 5:45pm (session: 4:30 - ...
Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 24 Nov 2009 16:50 GMT
... Tyrosine Kinase (RTK) Inhibitor, in a First-in-Human (FIH) Phase 1 AML Study Session Name: Acute Myeloid Leukemia - Therapy, excluding Transplantation II Date: Monday, December 7, 2009, 5:45pm (session: 4:30 - ...
Notice of Special Meeting of Stockholders of EpiCept Corporation 24 Nov 2009 05:34 GMT
... European Commission for the remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in first remission. The Company has two oncology drug candidates currently in clinical ...
Mutated IDH1 Gene Linked to Brain Cancer 24 Nov 2009 04:35 GMT
... mutation was also shown to be present in a significant percentage of patients with Acute Myeloid Leukemia, another devastating disease. The insight from this new research at Agios is the first ...

Woman meets the stranger who saved her life 23 Nov 2009 15:45 GMT
... a bone marrow biopsy revealed the grim details. Robinson had an aggressive cancer called acute myeloid leukemia (AML). Normally, the stem cells inside the marrow of our bones produce immature blood ...
Robert B. Gerbing Honored by Cambridge Who's Who 23 Nov 2009 14:31 GMT
... include performing data and statistical analysis for clinical trials including childhood cancer, neuroblastoma and acute myeloid leukemia, as well as coordinating with principle investigators regarding study design. He has published 58 ...
Agios Publishes Groundbreaking Research in Nature Uncovering the New Role of IDH1 Gene Mutation in Brain Cancer 23 Nov 2009 14:01 GMT
... mutation was also shown to be present in a significant percentage of patients with Acute Myeloid Leukemia, another devastating disease. The insight from this new research at Agios is the first ...
Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 22 Nov 2009 19:02 GMT
... mutation was also shown to be present in a significant percentage of patients with Acute Myeloid Leukemia, another devastating disease. The insight from this new research at Agios is the first ...
Three Distinct Domains Contribute to Nuclear Transport of Murine Foxp3 22 Nov 2009 10:35 GMT
... domain (FHD), recently reported to be a binding site for the runt-related transcription factor 1/acute myeloid leukemia 1 (Runx1/AML1). The third domain (Domain 3) is located within the N-terminal first 51 ...

Not satisfied with this news section? Make your own with the Newsletter Manager or try our other media monitoring services.

A Spectrum of Severe Familial Liver Disorders Associate with Telomerase Mutations 20 Nov 2009 22:36 GMT
... associated with severe telomere shortening and a range of hematologic manifestations, from macrocytosis to acute myeloid leukemia, with severe liver diseases marked by fibrosis and inflammation, and one case of idiopathic ...
Sunesis Reports Financial Results for the Third Quarter of 2009 19 Nov 2009 18:32 GMT
... 2009. Sunesis also announced that two abstracts related to the voreloxin clinical program in Acute Myeloid Leukemia (AML) have been accepted for presentation at the 51st Annual Meeting of the American ...
Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML 19 Nov 2009 15:40 GMT
... Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) MONTREAL , Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc. announced today the dosing ...
Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 19 Nov 2009 15:11 GMT
... MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc. announced today the dosing of the first patient in a ...
Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) (CNW) 19 Nov 2009 15:10 GMT
... "Strong demonstration of activity in our non-randomized Phase 2A study conducted in this indication have encouraged us ...
Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) (PRN) 19 Nov 2009 15:10 GMT
... "Strong demonstration of activity in our non-randomized Phase 2A study conducted in this indication have encouraged us ...
Health: Terra med Alliance News Two Units of Umbilical Cord Blood Reduce Risk of Leukemia 19 Nov 2009 02:31 GMT
... study was 16 years. Eighty-eight patients had acute lymphoblastic leukemia (ALL) and 89 had acute myeloid leukemia (AML). "Our analysis showed that patients in first or second remission from the leukemia ...
Sunesis Reports Data From Nonclinical Studies of Voreloxin at AACR-EORTC-NCI 18 Nov 2009 18:34 GMT
... Phase 2 clinical study of voreloxin in combination with cytarabine in relapsed or refractory acute myeloid leukemia (AML). In an additional study, voreloxin's synergistic and additive effects are demonstrated in combination ...
Sunesis Reports Data From Nonclinical Studies of Voreloxin at AACR-EORTC-NCI Conference 18 Nov 2009 17:50 GMT
... Phase 2 clinical study of voreloxin in combination with cytarabine in relapsed or refractory acute myeloid leukemia (AML). In an additional study, voreloxin's synergistic and additive effects are demonstrated in combination ...
Celgene and Innate Collaborate on Trial Combining Their Multiple Myeloma Therapies 18 Nov 2009 16:42 GMT
... multiple myeloma known as smoldering myeloma. A Phase I trial evaluating IPH 2101 in acute myeloid leukemia was also recently extended. Revlimid is an immunomodulatory therapy and is also approved for ...

THESE STORIES ARE NOT PUBLISHED BY IPD GROUP, INC. AND THESE LINKS WILL TAKE YOU TO OTHER WEBSITES. SOME OF THESE WEBSITES REQUIRE THEIR OWN REGISTRATION TO READ THEIR STORIES. PLEASE READ THE DISCLAIMER FOR MORE DETAILS. >>>

Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090 18 Nov 2009 13:31 GMT
... (GIST), prostate cancer, colon cancer, breast cancer, gastric cancer, pancreatic cancer, colon cancer, melanoma, acute myeloid leukemia, chronic myeloid leukemia, acute lymphoblastic leukemia, B-cell lymphoma, and multiple myeloma. Potent activity was ...
Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090 - Broad anti-cancer activity as a single agent and in combination 18 Nov 2009 13:30 GMT
... (GIST), prostate cancer, colon cancer, breast cancer, gastric cancer, pancreatic cancer, colon cancer, melanoma, acute myeloid leukemia, chronic myeloid leukemia, acute lymphoblastic leukemia, B-cell lymphoma, and multiple myeloma. Potent activity was ...
Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090 (BIZ) 18 Nov 2009 13:30 GMT
... as non-small cell lung cancer, gastric carcinoma and melanoma and hematologic malignancies such as acute myeloid leukemia, B-cell lymphoma, chronic myeloid leukemia and multiple myeloma. Activity was demonstrated in models that ...
St. Croix architect who championed bone marrow donations dies 17 Nov 2009 22:18 GMT
... on and the work has just begun," Sutherland said. Khephra, who was diagnosed with acute myeloid leukemia in April, needed a bone marrow transplant. When a donor match could not be ...
Lipoxen plc New Research Collaboration with Pharmsynthez 17 Nov 2009 13:32 GMT
... Pharmsynthez’s compounds in multiple sclerosis, HIV and non-Hodgkin lymphoma as well as cystic fibrosis, acute myeloid leukemia and type 2 diabetes. Given that the commitment of upfront resources is limited to ...